# Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

> **NCT06834035** · PHASE1,PHASE2 · RECRUITING · sponsor: **M. Peter Marinkovich** · enrollment: 8 (estimated)

## Conditions studied

- Epidermolysis Bullosa
- Epidermolysis Bullosa Acquisita
- Dystrophic Epidermolysis Bullosa
- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

- **BIOLOGICAL:** Immunoglobulin G

## Key facts

- **NCT ID:** NCT06834035
- **Lead sponsor:** M. Peter Marinkovich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834035, "Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06834035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*